Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
07/05/2006 | CN1795843A Control release system for medication in zero order |
07/05/2006 | CN1795838A Cotton bar, cotton bar type suppository and preparing technique |
07/05/2006 | CN1262556C Certain dinucleotides and their use as membrana mucosa cilium clearing and cilium vibration frequency regulating agent |
07/05/2006 | CN1262456C Method and device for producing thin wafers from a film of active ingredients |
07/05/2006 | CN1262311C Medicinal composition for target direction transport curing cancer and its usage |
07/05/2006 | CN1262308C Use of enzymes obtained from ciliates as medicaments for promoting digestion |
07/05/2006 | CN1262301C Medicine for drug rehabilitation |
07/05/2006 | CN1262299C Chinese medicine adhesive film for preventing and treating coronary heart disease and angina pectoris and its preparing method |
07/05/2006 | CN1262298C Externally applied medicine for treating hyperosteogeny and preparation method thereof |
07/05/2006 | CN1262297C Chinese medicine for treating irritable bowel syndrome and preparing method thereof |
07/05/2006 | CN1262295C Health care medicine capable of strengthening heart and kidney function and immunologic function |
07/05/2006 | CN1262294C Ginseng and aconite injection liquid for treating qi vacuity and yang desertion and its preparation method |
07/05/2006 | CN1262293C Ginseng and aconite preparation for treating qi vacuity yang desertion and its extraction method |
07/05/2006 | CN1262289C Application of antimonocytic activity of extracts of piper betel leaves |
07/05/2006 | CN1262288C Preparing method of licorice extracturm by means of producing refuse with glycyrrhizin |
07/05/2006 | CN1262285C Liniment for skin and its preparation |
07/05/2006 | CN1262278C Antiacid and laxative tablets |
07/05/2006 | CN1262277C Injection of low molecular weight chondroitin sulfate and its preparation method |
07/05/2006 | CN1262275C Anticancer |
07/05/2006 | CN1262270C Application of levocarnitine and its derivative in preventing and treating high altitude diseases |
07/05/2006 | CN1262213C Water containing soluble fiber |
07/04/2006 | US7071233 Microbe inhibitors comprising antimicrobial isolates, botanical extracts or phytochemicals; also Commiphora myrrha, Commiphora molmol, Commiphora erythraea, sequiterpenes, nutrient, a vitamin, or a vitamin B complex. |
07/04/2006 | US7071214 Compounds and compositions for delivering active agents |
07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
07/04/2006 | US7071203 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon |
07/04/2006 | US7070828 Process for coating solid particles |
07/04/2006 | US7070825 Infant formula |
07/04/2006 | US7070817 Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases |
07/04/2006 | US7070812 Process for producing dry powders of one or more carotenoids |
07/04/2006 | US7070811 Directly compressible formulations of azithromycin |
07/04/2006 | US7070810 Use of buckysome or carbon nanotube for drug delivery |
07/04/2006 | US7070809 Hydrogel biomedical articles |
07/04/2006 | US7070808 Comprising an adhesive, drug in protonated form, a nonaqueous solvent capable of dissolving nonprotonated and protonated forms of the drug, and a biocompatible deprotonating agent to deprotonate the drug without irritating the skin |
07/04/2006 | US7070807 Administering polypeptide by injection; gene therapy |
07/04/2006 | US7070806 Controlled release formulations coated with aqueous dispersions of acrylic polymers |
07/04/2006 | US7070805 Comprises a pharmacologically active ingredient, a sugar and a low-substituted hydroxypropylcellulose having 5 to 7% by weight of hydroxypropyl group; fast disintegrability, suitable strength and no roughness |
07/04/2006 | US7070804 Vitamin tablet enhancing appetite and calcium absorption |
07/04/2006 | US7070803 Controlled release pharmaceutical composition for oral use containing midodrine and/or active metabolite, desglymidodrine |
07/04/2006 | US7070802 a cyclosporin and a carrier medium comprising a polyethylene glycol glyceryl fatty acid ester, a monoglyceride, diglyceride, and/or medium-chain triglyceride, and a surfactant for oral administration; forms a clear, fine emulsion when contacted with water |
07/04/2006 | US7070801 Drug delivery system |
07/04/2006 | US7070800 Inhalable powder containing tiotropium |
07/04/2006 | US7070799 Method for administering insulin to the buccal region |
07/04/2006 | US7070798 Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine |
07/04/2006 | US7070796 Pharmaceutically stable oxaliplatinum preparation for parenteral administration |
07/04/2006 | US7070766 Delivery of physiologically active compounds through an inhalation route |
07/04/2006 | US7070765 condensation aerosol formed by heating a thin layer containing the ester, on a solid support to produce a vapor of the ester, and condensing the vapor; less than 10% ester degradation products by weight, and a Mass median aerodynamic diameter of less than 5 microns. |
07/04/2006 | US7070764 Delivery of analgesics through an inhalation route |
07/04/2006 | US7070763 Delivery of diphenhydramine through an inhalation route |
07/04/2006 | US7070762 Delivery of analgesics through an inhalation route |
07/04/2006 | US7070761 Aerosols; heating, vaporization, cooling |
07/04/2006 | US7070722 for medical or veterinary use; gelling agent treated with a first precipitant which is calcium citrate and/or calcium-releasing water-soluble glass to stabilize the gelling agent; foaming and curing; immersing foam in a second calcium precipitant; sterlizing with gamma radiation or ethylene oxide |
07/04/2006 | US7070656 Electrostatic coating |
07/04/2006 | US7070605 Great saphenous vein varix treatment tool |
07/04/2006 | US7070592 Medical device with array of electrode-containing reservoirs |
07/04/2006 | US7070591 Vascular access port with physiological sensor |
07/04/2006 | US7070590 Microchip drug delivery devices |
07/04/2006 | CA2462452C Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid |
07/04/2006 | CA2414945C Cellulose powder |
07/04/2006 | CA2267091C Method for preparing microcapsules of active substances coated with a polymer and novel microcapsules in particular resulting from the method |
07/04/2006 | CA2247329C Composition containing antitumor agent |
07/04/2006 | CA2159419C Solid pharmaceutical composition comprising an excipient capable of binding water |
06/29/2006 | WO2006069344A2 Controlled release hydrogels |
06/29/2006 | WO2006069240A2 Composition and treatment methods for coronary artery disease |
06/29/2006 | WO2006069213A1 Pharmaceutical formulations |
06/29/2006 | WO2006069098A1 Nanoparticulate bicalutamide formulations |
06/29/2006 | WO2006069079A2 Methods and formulations |
06/29/2006 | WO2006069038A1 Therapeutic materials and methods |
06/29/2006 | WO2006069030A1 Pharmaceutical compositions for sleep disorders |
06/29/2006 | WO2006068921A2 Device for ophthalmic drug delivery |
06/29/2006 | WO2006068899A2 Preserved ophthalmic compositions comprising aloe vera |
06/29/2006 | WO2006068898A1 Reusable drug delivery device |
06/29/2006 | WO2006068890A2 Lipid particles comprising bioactive agents, methods of preparing and uses thereof |
06/29/2006 | WO2006068877A2 Sustained-release nanoparticle compositions and methods for using the same |
06/29/2006 | WO2006068759A2 Liposomes containing phytochemical agents and methods for making and using same |
06/29/2006 | WO2006068715A2 Cosmetic compositions having carnitine creatinate and methods for using |
06/29/2006 | WO2006068596A1 Solid dosage form comprising proton pump inhibitor and suspension made thereof |
06/29/2006 | WO2006068266A1 PROSTAGLANDIN F2α DERIVATIVE CONTAINING PRODUCTS |
06/29/2006 | WO2006068232A1 Drug carrier and drug carrier kit for inhibiting fibrosis |
06/29/2006 | WO2006068166A1 Dry granulated substance and process for producing the same |
06/29/2006 | WO2006068105A1 Therapeutic agent for keratoconjunctive disorder |
06/29/2006 | WO2006067605A1 Stable pharmaceutical compositions of tiagabine and processes for their preparation |
06/29/2006 | WO2006067601A1 Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation |
06/29/2006 | WO2006067600A2 Herbal formulations as cough lozenge |
06/29/2006 | WO2006067599A2 Stable oral benzimidazole compositions and process of preparation thereof |
06/29/2006 | WO2006067593A1 Orally disintegrating pharmaceutical compositions with sensory cue agents |
06/29/2006 | WO2006067576A1 Enteric coated azithromycin multiparticulates |
06/29/2006 | WO2006067514A1 Multilayered dosing systems |
06/29/2006 | WO2006067502A1 Treatment of inflammatory diseases |
06/29/2006 | WO2006066961A1 Solid pharmaceutical composition comprising valsartan |
06/29/2006 | WO2006066949A1 Compositions comprising an epothilone and production methods |
06/29/2006 | WO2006066932A1 Stable pharmaceutical composition comprising an active substance in the form of solid solution |
06/29/2006 | WO2006066930A1 Stable pharmaceutical composition comprising amoxicillin and clavulanic acid |
06/29/2006 | WO2006066907A1 Pharmaceutical formulations |
06/29/2006 | WO2006066870A1 Solid pharmaceutical compositions |
06/29/2006 | WO2006066868A2 Sustained release formulation comprising bisphosphonate |
06/29/2006 | WO2006066788A1 Transdermal plaster with progesterone a-specific ligands (prasl) as an active ingredient |
06/29/2006 | WO2006066780A1 Combinations of valategrast and montelukast for treating asthma |
06/29/2006 | WO2006066509A1 Injectable sustained release microspheric preparation of 3,3-diphenylpropylamine derivatives as muscarinic receptor antagonists |
06/29/2006 | WO2006066500A1 The preparation process of quinazoline derivatives and application for the manufacture for the treatment of tumor disease |
06/29/2006 | WO2006066399A1 Tablet formulation for sustained drug-release |